The Global Dry Powder Culture Medium Market was valued at USD 685 Million in 2025 and is projected to reach USD 1.12 Billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period (2025–2034). This growth is being driven by the expanding biopharmaceutical industry, soaring demand for biologics and vaccines, and the accelerating adoption of customized and serum-free formulations for advanced cell culture applications.

As the life sciences sector advances toward more complex therapeutics like cell and gene therapies, the foundation of successful production lies in high-quality, consistent culture media. In this blog, we profile the Top 10 Companies in the Dry Powder Culture Medium Industry—a mix of global life science giants and specialized innovators shaping the future of biomanufacturing and research.

---

🔟 1. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Gibco™ brand media, including powdered DMEM, RPMI 1640, and specialty formulations

Thermo Fisher Scientific is a world leader in serving science, and its Gibco™ brand is synonymous with high-quality cell culture media. The company offers an extensive portfolio of dry powder media that supports a wide range of applications, from basic academic research to large-scale commercial bioproduction. Their formulations are renowned for consistency and reliability, underpinning critical workflows in biopharmaceutical development.

Innovation and Growth Initiatives:

• Continuous expansion of cGMP-compliant, serum-free, and chemically defined media lines.

• Strategic acquisitions to bolster bioproduction capabilities and custom media services.

• Investment in digital tools to streamline media selection and ordering for customers.

Download FREE Sample Report: Dry Powder Culture Medium Market – View in Detailed Research Report

---

9️⃣ 2. Merck KGaA (Sigma-Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: SAFC® and Sigma-Aldrich® branded media, including powdered MEM, DMEM, and custom formulations

Merck KGaA, operating through its Sigma-Aldrich brand, is a cornerstone of the life science supply chain. Its SAFC® segment specializes in high-quality raw materials for biopharmaceutical manufacturing, offering a vast array of dry powder culture media. The company is a critical partner for the industry, providing both off-the-shelf and highly customized media solutions.

Innovation and Growth Initiatives:

• Development of advanced, xeno-free, and animal component-free media for sensitive applications.

• Focus on enhancing supply chain resilience and scalability for global customers.

---

8️⃣ 3. Sartorius AG

Headquarters: Göttingen, Germany
Key Offering: Biochrom™ media brands and specialty formulations for bioprocessing

Sartorius is a leading international partner for biopharmaceutical research and production. Following its acquisition of cell culture media specialist Biochrom, Sartorius has strengthened its position in the dry powder media market. The company provides integrated solutions, combining media with its renowned bioreactors and filtration systems, offering a complete ecosystem for cell culture.

Innovation and Growth Initiatives:

• Integration of media offerings with single-use bioprocessing equipment.

• R&D focused on media optimization for high-density cell culture and intensified processes.

---

7️⃣ 4. Cytiva (HyClone brand)

Headquarters: Marlborough, Massachusetts, USA
Key Offering: HyClone™ powdered cell culture media, including classical and specialty formulations

Cytiva, a global life sciences leader, offers the trusted HyClone™ brand of cell culture media. The company’s dry powder media are designed for performance and scalability, supporting customers from process development through to commercial manufacturing. Cytiva’s expertise in bioprocessing makes it a key enabler for the production of vaccines, monoclonal antibodies, and advanced therapies.

Innovation and Growth Initiatives:

• Expansion of advanced, chemically defined media portfolios.

• Partnerships with biopharma companies to co-develop custom media formulations.

Download FREE Sample Report: Dry Powder Culture Medium Market – View in Detailed Research Report

---

6️⃣ 5. FUJIFILM Irvine Scientific

Headquarters: Santa Ana, California, USA
Key Offering: Specialty dry powder media for assisted reproductive technology (ART), cell therapy, and bioproduction

FUJIFILM Irvine Scientific is a leading supplier of cell culture media with a strong focus on specialized, high-growth segments. The company is renowned for its expertise in media for ART and regenerative medicine. Their dry powder formulations are characterized by stringent quality control and are designed to meet the exacting requirements of sensitive cell types used in advanced therapies.

Innovation and Growth Initiatives:

• Pioneering cGMP-manufactured, serum-free media for clinical applications.

• Investment in media optimization for stem cell and organoid culture.

---

5️⃣ 6. Lonza Group AG

Headquarters: Basel, Switzerland
Key Offering: Powders of its proprietary media, such as PowerCHO™ and Xeno-Free media systems

Lonza is a premier provider of products and services to the pharmaceutical and biotech industries. While widely known for its contract development and manufacturing organization (CDMO) services, Lonza also supplies high-performance dry powder media through its bioscience solutions segment. Their media are specifically engineered to enhance productivity in mammalian cell culture systems.

Innovation and Growth Initiatives:

• Development of high-performance media kits designed to boost cell growth and recombinant protein yields.

• Focus on supplying media that are fully compatible with their own cell lines and bioprocessing platforms.

---

4️⃣ 7. Corning Incorporated

Headquarters: Corning, New York, USA
Key Offering: Powdered versions of its Cellgro® and other classic media formulations

Corning is a world leader in specialty glass, ceramics, and related materials, with a significant presence in the life sciences arena. The company provides a range of dry powder culture media under its Cellgro® brand, catering primarily to academic, government, and industrial research laboratories. Corning’s media are valued for their quality and consistency, supporting a broad spectrum of cell culture needs.

Innovation and Growth Initiatives:

• Synergistic offerings that pair media with Corning’s extensive portfolio of cell culture vessels and surfaces.

• Focus on providing reliable, foundational media for core research applications.

---

3️⃣ 8. HiMedia Laboratories

Headquarters: Mumbai, India
Key Offering: A wide range of cost-effective powdered microbiological and cell culture media

HiMedia Laboratories is a prominent global manufacturer of culture media, with a strong foothold in emerging markets. The company produces a comprehensive portfolio of dry powder media for both microbial and animal cell culture. HiMedia is recognized for offering high-quality products at competitive prices, making it a popular choice for educational institutions and cost-sensitive biotech firms.

Innovation and Growth Initiatives:

• Expansion of product lines to include more specialized and serum-free formulations.

• Strategic growth in international markets through an extensive distribution network.

---

2️⃣ 9. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: Powdered BBL™ and Difco™ brand microbiological media

BD is a global medical technology company with a long-standing heritage in microbiology. While its focus in media is stronger on the microbiological side with its classic BBL™ and Difco™ brands, these dry powder formulations are industry standards for clinical diagnostics and quality control labs. BD’s media are critical for ensuring product safety and sterility in the pharmaceutical industry.

Innovation and Growth Initiatives:

• Maintaining a legacy of quality and reliability in prepared culture media.

• Supporting pharmaceutical quality control and vaccine manufacturing processes.

---

1️⃣ 10. Caisson Laboratories, Inc.

Headquarters: Smithfield, Utah, USA
Key Offering: Specialty powdered plant tissue culture media and reagents

Caisson Laboratories specializes in providing high-purity ingredients and prepared media for plant tissue culture. Their dry powder media are essential tools for agricultural biotechnology, horticulture, and plant science research. The company has carved out a strong niche by focusing on the specific and often overlooked needs of the plant biology sector, offering consistent and reliable formulations.

Innovation and Growth Initiatives:

• Development of specialized media formulations for genetically modified plant production.

• Expansion of product offerings to support emerging applications in cannabis and other high-value crops.

Get Full Report Here: Dry Powder Culture Medium Market – View in Detailed Research Report

---

🧫 Outlook: The Future of Dry Powder Culture Medium Is Customized and High-Performance

The dry powder culture medium market is undergoing a significant transformation. While standard formulations continue to serve foundational research, the industry is increasingly investing in advanced, high-performance alternatives, sophisticated customization services, and formulations tailored for next-generation biotherapeutics.

📈 Key Trends Shaping the Market:

• Rapid adoption of chemically defined and serum-free media to enhance process control and regulatory compliance.

• Growing demand for custom-formulated media optimized for specific cell lines and complex processes like viral vector and CAR-T cell production.

• Continued preference for the logistical and stability advantages of dry powder formats in large-scale global biomanufacturing.

• Strategic partnerships between media suppliers and biopharma companies to co-develop proprietary media, creating a competitive edge.

Get Full Report Here: Dry Powder Culture Medium Market – View in Detailed Research Report

The companies listed above are not only supplying essential tools for life science—they’re enabling the next wave of biomedical innovation.